Mizuho Financial Group, Inc. - Price Target for Depositary Receipt (MFG) Raised by 23.98% to 7.37
Price Target Update: The average one-year price target for Mizuho Financial Group, Inc. (NYSE:MFG) has been raised to $7.37 per share, reflecting a 23.98% increase from the previous estimate of $5.94.
Fund Sentiment: There are currently 369 funds reporting positions in Mizuho Financial Group, with a 6.03% increase in ownership over the last quarter, and total shares owned by institutions rising by 8.36% to 210,967K shares.
Shareholder Activity: Major shareholders like Goldman Sachs and Bank of America have adjusted their holdings, with Goldman Sachs increasing its shares slightly while significantly reducing its portfolio allocation, and Bank of America also increasing its shares but decreasing its allocation.
Market Outlook: The put/call ratio for MFG stands at 0.32, indicating a bullish sentiment among investors regarding the stock's future performance.
Trade with 70% Backtested Accuracy
Analyst Views on MFG
About MFG
About the author

- Sales Growth Recovery: Starbucks' 'Back to Starbucks' initiative has successfully increased customer traffic, leading to a resurgence in comparable-store sales, although profitability remains below historical levels, indicating early signs of recovery.
- Profitability Challenges: Analysts expect the adjusted operating margin for Q2 FY2026 to reach 8.3%, a modest increase from last year, yet still far below the mid-to-upper teens margins seen pre-pandemic, reflecting the difficulties in profit recovery.
- Increased Cost Pressures: The operating margin has risen from 27.4% of sales in FY2019 to 31.9% in FY2025 due to rising wages and operational costs, presenting significant challenges for the company in enhancing profitability.
- Cautious Future Outlook: Starbucks projects an operating margin range of 13.5% to 15% by FY2028, although this target has disappointed Wall Street expectations, highlighting skepticism about the company's ability to restore profitability.
- Market Size Expectations: AI infrastructure spending is projected to reach approximately $700 billion by 2026, and despite investor concerns about peak spending, the underlying market opportunity remains significant, particularly as large tech companies report strong revenue growth.
- Nvidia's Strong Growth: Nvidia's revenue for fiscal 2026 is expected to surge 65% year-over-year to $215.9 billion, driven largely by aggressive data center investments, with CEO Jensen Huang forecasting a data center AI opportunity exceeding $1 trillion, reflecting robust demand for its products.
- Taiwan Semiconductor's Key Role: Taiwan Semiconductor's revenue rose 39% year-over-year to $35.9 billion in Q1 2026, showcasing its strong pricing power in high-performance computing and advanced nodes, with management expecting revenue growth above 30% in 2026.
- Microsoft's Steady Growth: Microsoft anticipates a 16.2% year-over-year revenue increase to $81.4 billion in Q3 2026, driven by its cloud platform and long-term contracts, highlighting its long-term potential and leadership position in the AI sector.
- Market Dominance: Nvidia's revenue for fiscal 2026 reached $215.9 billion, a 65% year-over-year increase, primarily driven by aggressive investments from hyperscalers, underscoring its crucial role in global AI infrastructure development.
- Strong Growth Outlook: Taiwan Semiconductor Manufacturing reported a 39% year-over-year revenue increase to $35.9 billion in Q1 2026, with gross margin rising to 66.2%, and expects revenue growth above 30% year-over-year in 2026, highlighting its significance in AI demand.
- Custom Chip Demand: Broadcom anticipates a 47% year-over-year revenue growth to around $22 billion in Q2 2026, with AI semiconductor revenue projected to rise 140% to $10.7 billion, indicating its key role in building AI systems.
- Government Contract Support: Palantir's $10 billion contract with the U.S. military ensures long-term stable revenue, while its AI platform is rapidly gaining traction across various industries, enhancing its competitive position in the market.
- AI Investment Strategy: An AI agent based on Anthropic's Claude models counterintuitively increased its positions in Microsoft and Broadcom, allocating 10% and 8% of the portfolio respectively, demonstrating high confidence in expected returns exceeding 20%, highlighting AI's unique advantage in risk assessment.
- Microsoft's Valuation Opportunity: Despite a 28% drop in Microsoft's stock price prior to the Iran ceasefire, Claude views its 20x forward P/E ratio as undervalued compared to the software sector average, indicating a market mispricing of its cloud platform, with expectations that growth from Azure and Copilot will make current valuation compression temporary.
- Broadcom's Market Dominance: Claude identifies Broadcom as the

- AI Investment Strategy: Anthropic's Claude model identified Microsoft and Broadcom as high-conviction buys following the Iran ceasefire announcement, leading to a surge in both stocks, showcasing AI's unique advantages in navigating market volatility.
- Microsoft Valuation Insight: Despite a 28% drop in Microsoft's stock price this year, Claude views its 20x forward P/E ratio as undervalued compared to the software sector average, indicating a market mispricing that could lead to significant future earnings recovery.
- Broadcom's Market Position: Claude allocated 10% of its portfolio to Broadcom, recognizing its 60%-80% share in the custom AI chip market, with projected orders reaching $100 billion by 2027, highlighting strong growth potential.
- Long-Term Growth Outlook: The AI model sees Microsoft and Broadcom as pivotal players in the next decade of AI development, and while the market remains cautious about semiconductor cyclical risks, Claude identifies structural growth inevitability.
- Impact of Medicare Policy: The CMS's finalized Medicare payment increase of nearly 2.5% significantly improves the profitability outlook for CVS and other healthcare stocks, leading to a stock price rebound compared to the previously proposed 0.09% increase.
- Upgraded Earnings Expectations: Analysts project CVS's earnings per share to reach between $7 and $7.20 in 2026, with the increase in Medicare payments likely enhancing CVS's profitability and boosting market confidence.
- Stock Valuation Potential: Currently trading at around 11 times forward earnings, CVS could see its stock price rise to $90 or $100 if it narrows the valuation gap with competitors like UnitedHealth Group, offering substantial investment returns.
- Stable Dividend Yield: With a forward dividend yield of 3.4%, CVS not only provides steady income but also attracts long-term investors, further supporting the upward momentum of its stock price.










